Drug Search Results
More Filters [+]

Manidipine

Alternative Names: manidipine
Latest Update: 2024-04-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: L-Type Calcium Channel Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | China | Egypt | France | Greece | Italy | Korea | Morocco | Portugal | Spain | Thailand | Tunisia | Turkey | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Chiesi
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Manidipine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hypertension

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20200873

N/A

Completed

Hypertension

2020-10-26

KUGH15082 (MAAMA)

P4

Terminated

Hypertension

2018-05-15

MANTRA

P4

Completed

Hypertension

2009-02-28

MANTRA

P3

Completed

Hypertension

2008-12-01

Recent News Events